Orforglipron is a "non-peptide" or "small molecule" GLP-1 agonist, meaning it is a synthetic chemical compound that activates the same GLP-1 receptor but is not an amino acid chain
Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy
Took, PharmD, BCACP Assistant Professor of Pharmacy Practice St
WeightWatchers, which recently acquired Sequence, a telehealth company that prescribes GLP-1 medicine, created a special diet plan for those on the drugs
Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels
(2025, June 25)